Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey.
Humans
Uterine Cervical Neoplasms
/ prevention & control
Female
Africa South of the Sahara
/ epidemiology
HIV Infections
/ prevention & control
Adult
Papillomavirus Vaccines
/ administration & dosage
Papillomavirus Infections
/ prevention & control
Middle Aged
Young Adult
Surveys and Questionnaires
Health Services Accessibility
HIV
cervical cancer prevention
monitoring
outcomes
prevention and care cascades
sub‐Saharan Africa
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
received:
13
07
2023
accepted:
21
05
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
9
7
2024
Statut:
ppublish
Résumé
To eliminate cervical cancer (CC), access to and quality of prevention and care services must be monitored, particularly for women living with HIV (WLHIV). We assessed implementation practices in HIV clinics across sub-Saharan Africa (SSA) to identify gaps in the care cascade and used aggregated patient data to populate cascades for WLHIV attending HIV clinics. Our facility-based survey was administered between November 2020 and July 2021 in 30 HIV clinics across SSA that participate in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. We performed a qualitative site-level assessment of CC prevention and care services and analysed data from routine care of WLHIV in SSA. Human papillomavirus (HPV) vaccination was offered in 33% of sites. Referral for CC diagnosis (42%) and treatment (70%) was common, but not free at about 50% of sites. Most sites had electronic health information systems (90%), but data to inform indicators to monitor global targets for CC elimination in WLHIV were not routinely collected in these sites. Data were collected routinely in only 36% of sites that offered HPV vaccination, 33% of sites that offered cervical screening and 20% of sites that offered pre-cancer and CC treatment. Though CC prevention and care services have long been available in some HIV clinics across SSA, patient and programme monitoring need to be improved. Countries should consider leveraging their existing health information systems and use monitoring tools provided by the World Health Organization to improve CC prevention programmes and access, and to track their progress towards the goal of eliminating CC.
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e26303Subventions
Organisme : Swiss National Science Foundation (r4d program)
ID : 177319
Organisme : U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases
Organisme : Eunice Kennedy Shriver National Institute of Child Health and Human Development
Organisme : NCI NIH HHS
Pays : United States
Organisme : NIMH NIH HHS
Pays : United States
Organisme : NIDA NIH HHS
Pays : United States
Organisme : NHLBI NIH HHS
Pays : United States
Organisme : NIAAA NIH HHS
Pays : United States
Organisme : NIDDK NIH HHS
Pays : United States
Organisme : FIC NIH HHS
Pays : United States
Organisme : Central Africa
ID : U01AI096299
Organisme : East Africa
ID : U01AI069911
Organisme : Southern Africa
ID : U01AI069924
Organisme : West Africa
ID : U01AI069919
Organisme : Harmonist project
ID : R24AI24872
Organisme : European Union's Horizon 2020 research and innovation program (Marie Skłodowska-Curie grant)
ID : 801076
Informations de copyright
© 2024 The Author(s). Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
Références
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020.
Viviano M, Debeaudrap P, Tebeu P‐M, Tsuala Fouogue J, Vassilakos P, Petignat P. A review of screening strategies for cervical cancer in human immunodeficiency virus‐positive women in sub‐Saharan Africa. Int J Womens Health. 2017;9:69–79.
WHO guideline for screening and treatment of cervical pre‐cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021.
World Health Organization. Comprehensive cervical cancer control: a guide to essential practice–2nd ed. 2014.
World Health Organization. Monitoring national cervical cancer prevention and control programmes: quality control and quality assurance for visual inspection with acetic acid (VIA)‐based programmes. 2013.
UICC/IARC/AFCRN. Cervical cancer elimination in Africa: where we are now and where we need to be? 2022. http://globalink.uicc.org/resources/cervical‐cancer‐elimination‐africa‐where‐are‐we‐now‐and‐where‐do‐we‐need‐be. Accessed 17 June 2022.
Huchko MJ, Maloba M, Nakalembe M, Cohen CR. The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV‐positive women in low‐income countries. J Int AIDS Soc. 2015;18(Suppl 5):20282. https://doi.org/10.7448/IAS.18.6.20282
Korn AK, Muzingwani L, O'bryan G, Ensminger A, Boylan AD, Kafidi E‐L, et al. Cervical cancer screening and treatment, HIV infection, and age: program implementation in seven regions of Namibia. PLoS One. 2022;17(2):e0263920.
Afzal O, Lieber M, Dottino P, Beddoe AM. Cervical cancer screening in rural South Africa among HIV‐infected migrant farm workers and sex workers. Gynecol Oncol Rep. 2017;20:18–21.
Sarah Maria N, Olwit C, Kaggwa MM, Nabirye RC, Ngabirano TD. Cervical cancer screening among HIV‐positive women in urban Uganda: a cross sectional study. BMC Womens Health. 2022;22(1):148.
White HL, Meglioli A, Chowdhury R, Nuccio O. Integrating cervical cancer screening and preventive treatment with family planning and HIV‐related services. Int J Gynaecol Obstet. 2017;138(Suppl 1):41–46.
Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero‐Liceras F, et al. Integrating cervical cancer with HIV healthcare services: a systematic review. PLoS One. 2017;12(7):e0181156.
Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207–223. https://doi.org/10.1016/j.ejca.2019.12.013
Rohner E, Mulongo M, Pasipamire T, Oberlin AM, Goeieman B, Williams S, et al. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africaa. Int J Gynaecol Obstet. 2021;152(1):53–59.
Pry JM, Manasyan A, Kapambwe S, Taghavi K, Duran‐Frigola M, Mwanahamuntu M, et al. Cervical cancer screening outcomes in Zambia, 2010–19: a cohort study. Lancet Glob Health. 2021;9(6):e832–e840.
Taghavi K, Mandiriri A, Shamu T, Rohner E, Bütikofer L, Asangbeh S, et al. Cervical Cancer Screening Cascade for women living with HIV: a cohort study from Zimbabwe. PLOS Glob Public Health. 2022;2(2):e0000156.
World Health Organization. Improving data for decision‐making: a toolkit for cervical cancer prevention and control programmes. Geneva: World Health Organization; 2018.
World Health Organization. HIV strategic information for impact: cascade data use manual: to identify gaps in HIV and health services for programme improvement: user manual. World Health Organization; 2018.
Bruni L, Saura‐Lázaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019. Prev Med. 2021;144:106399.
Amponsah‐Dacosta E, Kagina BM, Olivier J. Health systems constraints and facilitators of human papillomavirus immunization programmes in sub‐Saharan Africa: a systematic review. Health Policy Plan. 2020;35(6):701–717.
Zheng L, Wu J, Zheng M. Barriers to and facilitators of human papillomavirus vaccination among people aged 9 to 26 years: a systematic review. Sex Transm Dis. 2021;48(12):e255–e262.
Toor J, Li X, Jit M, Trotter CL, Echeverria‐Londono S, Hartner A‐M, et al. COVID‐19 impact on routine immunisations for vaccine‐preventable diseases: projecting the effect of different routes to recovery. Vaccine. 2022;40(31):4142–4149.
Shet A, Carr K, Danovaro‐Holliday MC, Sodha SV, Prosperi C, Wunderlich J, et al. Impact of the SARS‐CoV‐2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health. 2022;10(2):e186–e194.
Spayne J, Hesketh T. Estimate of global human papillomavirus vaccination coverage: analysis of country‐level indicators. BMJ Open. 2021;11(9):e052016. Published 2021 Sep 2. https://doi.org/10.1136/bmjopen-2021-052016
Taghavi K, Mandiriri A, Shamu T, Rohner E, Bütikofer L, Asangbeh S, et al. Cervical Cancer Screening Cascade for women living with HIV: a cohort study from Zimbabwe. PLOS Glob Public Health. 2022;2(2):e0000156.
Lee H, Kang Y, Ju W. Cervical cancer screening in developing countries: using visual inspection methods. Clin J Oncol Nurs. 2016;20(1):79–83.
George Bush Institute. Strategies for accelerating access to treatment for advanced cervical cancer in sub‐Saharan Africa. 2021. www.gofurther.org. Accessed 5 Sept 2023.
Griesel M, Seraphin TP, Mezger NCS, Hämmerl L, Feuchtner J, Joko‐Fru WY, et al. Cervical cancer in sub‐Saharan Africa: a multinational population‐based cohort study of care and guideline adherence. Oncologist. 2021;26(5):e807–e816.
Erwin E, Aronson KJ, Day A, Ginsburg O, Macheku G, Feksi A, et al. SMS behaviour change communication and eVoucher interventions to increase uptake of cervical cancer screening in the Kilimanjaro and Arusha regions of Tanzania: a randomised, double‐blind, controlled trial of effectiveness. BMJ Innov. 2019;5(1):28–34.
Wanyoro AK, Kabiru EW. Use of mobile phone short text message service to enhance cervical cancer screening at Thika Level 5 Hospital, Kiambu County, Kenya: a randomised controlled trial. J Obstet Gynaecol Res. 2017;5(1):10–20. https://doi.org/10.5923/j.rog.20170501.03
Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh J, Fuhngwa N, et al. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Womens Health. 2021;21(1):74.
Owenga JA, Nyambedha EO. Perception of cervical cancer patients on their financial challenges in Western Kenya. BMC Health Serv Res. 2018;18(1):261.
Marth C, Landoni F, Mahner S, Mccormack M, Gonzalez‐Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol. 2017;28(suppl_4):iv72–iv83.
Drummond JL, Were MC, Arrossi S, Wools‐Kaloustian K. Cervical cancer data and data systems in limited‐resource settings: challenges and opportunities. Int J Gynaecol Obstet. 2017;138(Suppl 1):33–40.
Davidović M, Asangbeh SL, Taghavi K, Dhokothera T, Jaquet A, Musick B, et al. Facility‐based indicators to manage and scale up cervical cancer prevention and care services for women living with HIV in sub‐Saharan Africa: three‐round modified Delphi consensus method. J Acquir Immune Defic Syndr 2022;95(2):170–178.
Walther B, Hossin S, Townend J, Abernethy N, Parker D, Jeffries D. Comparison of electronic data capture (EDC) with the standard data capture method for clinical trial data. PLoS One. 2011;6(9):e25348. https://doi.org/10.1371/journal.pone.0025348